A Phase 1 Study in Patients with HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma

Active:	No
Cancer Type:	Head and Neck Cancer Skin Cancer (Non-Melanoma) Unknown Primary	NCT ID:	NCT03978689
Trial Phases:	Phase I	Protocol IDs:	Cue-101-01 (primary) NCI-2019-04589
Eligibility:	18 Years and older, Male and Female	Study Type:	Treatment
Study Sponsor:	Cue BioPharma
NCI Full Details:	http://clinicaltrials.gov/show/NCT03978689

Summary

This is a multi-center, open-label, phase 1 dose escalation and expansion study
evaluating the safety, anti-tumor effect, and immunogenicity of CUE-101 as monotherapy
treatment in second line or CUE-101 Combination Therapy with Pembrolizumab in first line
patients with HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Objectives

CUE-101 is a novel fusion protein designed to activate and expand a population of tumor
specific T cells to eradicate human papilloma virus (HPV)-driven malignancies. HPV causes
multiple tumor types including cervical, head and neck squamous cell carcinoma (HNSCC)
and anal cancers. Initial testing of CUE-101 will be conducted in HPV16+ HNSCC patients.

The primary objectives of the Part A&B, first-in-human trial, are to assess the safety
and tolerability of CUE-101 in subjects with recurrent/metastatic HNSCC in the second
line setting and to determine the maximum tolerated dose or recommended Phase 2 dose
based on markers of biological activity. Pharmacokinetics (PK), antitumor immune
response, preliminary antitumor activity and the potential for immunogenicity will also
be assessed. The goal of Part C&D is to characterize the safety, tolerability, and
biological effects of CUE-101 in combination with pembrolizumab in patients with
recurrent/metastatic HNSCC in the first line setting. This will be an open-label
multicenter phase I trial conducted in the U.S. involving approximately 85 patients.

Treatment Sites in Georgia

Emory University Hospital - Atlanta
1364 Clifton Road NE
Atlanta, GA 30322
www.emoryhealthcare.org

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.